Healthcare - Biotechnology - NASDAQ - US
$ 2.89
-16.2 %
$ 237 M
Market Cap
-1.62
P/E
INCOME STATEMENT
154 M
REVENUE
-89.3 M
OPERATING INCOME
-107 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Sutro Biopharma, Inc.
| Revenue | 154 M |
| Cost Of Revenue | 180 M |
| Gross Profit | -26.7 M |
| Operating Expenses | 243 M |
| Operating Income | -89.3 M |
| Other Expenses | 17.5 M |
| Net Income | -107 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 153.7 | 67.8 | 61.9 | 42.7 | 42.7 | 38.4 | 51.7 | 59.7 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 180.4 | 8.3 | 9.8 | 77.0 | 65.6 | 54.3 | 51.9 | 43.5 |
| Gross Profit | (26.7) | 59.5 | 52.1 | (34.2) | (22.9) | (15.8) | (0.2) | 16.2 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 243.0 | 196.7 | 160.4 | 113.8 | 98.2 | 75.6 | 71.0 | 58.4 |
| Selling, General and Administrative Expenses | 62.6 | 59.5 | 56.0 | 36.8 | 32.6 | 21.4 | 16.4 | 14.8 |
| Research and Development Expenses | 180.4 | 137.2 | 104.4 | 77.0 | 65.6 | 54.3 | 54.6 | 43.5 |
| Operating Income | (89.3) | (128.9) | (98.5) | (71.1) | (55.5) | (37.2) | (19.3) | 1.4 |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 23.8 | 3.3 | 3.1 | 4.1 | 4.3 | 1.6 | 0.6 | 0 |
| Total Other Income | 0.7 | 12.2 | (7.0) | 38.9 | (0.3) | 1.9 | (0.4) | 0.3 |
| Pre-Tax Income | (88.6) | (116.7) | (105.5) | (32.1) | (55.7) | (35.3) | (19.7) | 1.7 |
| NET INCOME | ||||||||
| Tax Provision | 18.2 | 2.5 | 3.1 | 4.1 | 8.7 | 3.5 | 0.5 | 87 K |
| Net Income | (106.8) | (119.2) | (108.7) | (36.2) | (55.7) | (35.3) | (19.7) | 1.7 |
| EPS | 1.78 | 2.35 | 2.36 | 1.11 | 2.43 | 6.13 | 2.81 | 0.24 |